MABp1
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MABp1, covering 2017-03-01 to 2021-02-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes [Phase 2]